Utama › Tekanan Darah Tinggi › Texas › Dallas
Kajian klinikal Tekanan Darah Tinggi di Dallas, TX
16 kajian untuk Tekanan Darah Tinggi sedang mencari peserta di lokasi dalam dan sekitar Dallas (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Mengambil pesertaFasa 2
- Retension Clinical Site, Dallas
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Mengambil peserta
- Baylor Scott & White Research Institute, Dallas
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Mengambil pesertaFasa 3
- Soltero Cardiovascular Research Center, Dallas
- North Texas Endocrine Center, Dallas
- Southwest Family Medicine Associates, Dallas
- dan 1 lagi
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Mengambil pesertaFasa 3
- Cedar Health Research - Texas Native Health, Dallas
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Mengambil pesertaFasa 3
- Research Site, Dallas
- Research Site, Dallas
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Mengambil pesertaFasa 3
- Clinical Trial Site, Dallas
- Clinical Trial Site, Dallas
- Clinical Trial Site, Dallas
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
- University of Texas Southwestern Medical Center, Dallas
IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
Mengambil pesertaSukarelawan sihat dialu-alukan
- Parkland Hospital, Dallas
Global Paradise System US Post Approval Study
Mengambil pesertaKajian pemerhatian
- Dallas VAMC, Dallas
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Mengambil pesertaKajian pemerhatian
- UT Southwestern Medical Center, Dallas
Polypill for Prevention of Cardiomyopathy
Mengambil pesertaFasa 1/2
- UT Southwestern Medical Center, Dallas
A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
Mengambil peserta
- Zenos Clinical Research, Dallas
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
Mengambil peserta
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
SPYRAL GEMINI Pilot Study
Mengambil peserta
- Baylor Heart & Vascular Hospital, Dallas
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
Mengambil peserta
- UT Southwestern Medical Center, Dallas
Preventing Cognitive Decline by Reducing BP Target Trial
Mengambil peserta
- UT Southwestern Medical Center, Dallas
Kajian Tekanan Darah Tinggi di bandar lain
- Chicago, IL22 kajian
- Boston, MA21 kajian
- Nashville, TN13 kajian
- Houston, TX11 kajian
- Birmingham, AL11 kajian
- Tucson, AZ10 kajian
- Atlanta, GA10 kajian
- Durham, NC10 kajian
- New York City, NY9 kajian
- Miami, FL9 kajian
- Baltimore, MD9 kajian
- Pittsburgh, PA8 kajian
Kajian lain di Dallas
- Kanser Payudara55 kajian
- Kanser Paru-paru Bukan Sel Kecil52 kajian
- Kanser Metastatik42 kajian
- Kegagalan Jantung42 kajian
- Kanser (semua jenis)37 kajian
- Kanser Prostat36 kajian
- Kanser Kolorektal33 kajian
- Obesiti30 kajian
- Kanser Ovari28 kajian
- Kanser Pundi Kencing27 kajian
- Kanser Paru-paru27 kajian
- Kanser Endometrium24 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.